Best Stocks to Buy Now

Best stocks to buy

To compile the list of the best stocks to buy, we looked for high-quality companies with solid fundamentals like strong earnings and revenue growth, as well as free cash flow, and many with a value tilt as measured by their forward price-to-earnings (P/E) ratios. 

The names featured here vary by size and industry and are not meant to compose a diversified portfolio. But all, for one reason or another, are well positioned to benefit in an uncertain market environment.

Coca-Cola

• Sector: Consumer staples
• Market value: $260.5 billion
• Dividend yield: 3.2%

Coca-Cola (KO) is a stronger company than it was at the start of the pandemic, after slimming its offerings by 600 products and moving away from sugary sodas with acquisitions such as coffee company Costa, says Argus Research analyst Taylor Conrad. 

Coke beat analysts' top-line expectations in the most recent quarter. Operating profit margins widened, too. More of the same is expected in 2024, says Conrad. 

Shares are a bargain as well, after slipping nearly 5% in 2023. Coke is one of the best dividend stocks too – it has raised its dividend for 62 consecutive years. At its current price, it boasts a 3.2% dividend yield. 

Cadence Design Systems

• Sector: Technology
• Market value: $86.1 billion
• Dividend yield: N/A

Chip designs are increasingly complex, and that's driving demand for Cadence Design Systems' (CDNS) products, which help companies design and test semiconductors. Customers such as Nvidia (NVDA), Broadcom (AVGO) and Tesla (TSLA) can't stay away. 

Cadence's sales related to artificial intelligence (AI) tripled in 2023, and analysts at Zacks Investment Research expect even faster growth in 2024. They predict earnings growth of 17% over each of the next three years, which is why CDNS is on this list of the best stocks to buy. 

But the tech stock is pricey, so snap up shares on dips. Competition is stiff in the electronic design automation space – Cadence is number two – and that may create opportunities as firms jockey for market share in this fast-growing industry. 

Diamondback Energy

• Sector: Energy
• Market value: $35.1 billion
• Dividend yield: 4.1%

Diamondback Energy (FANG), with a market value of $35 billion, is the premier pure-play shale driller in the Southwest's Permian Basin, according to analysts at The Carson Group, an investment management firm. Diamondback has an exceptionally low cost of production, they note, and generates attractive free cash flow – a key factor for those seeking out the best stocks to buy. 

"If you're bullish on oil prices, which we are, then Diamondback is a good bet," they say. 

Income-oriented investors will appreciate Diamondback's juicy 4.1% yield. And the shares trade at just 11.3 times the consensus of analysts' expected earnings for the next 12 months. The consensus price target for Diamondback's shares is an average $201.32, which implies a gain of more than 2% from the energy stock's recent close.

Delta Air Lines

• Sector: Industrials
• Market value: $29.2 billion
• Dividend yield: 0.9%

Despite turbulence elsewhere in the travel industry, Delta Air Lines (DAL) is on a smooth course, with the seatbelt sign switched off for investors, according to analysts at Morgan Stanley, where Delta is a top pick. 

Delta should generate per-share earnings of $7-plus in 2024 and more than $10 per share beyond, "which is still not close to being priced into the stock," they say. Domestic flights are "holding up" while corporate and international travel remain "robust." 

Morgan Stanley analysts believe Delta's management has been conservative in its guidance about fuel costs but acknowledge potential volatility there. Still, the analysts see the stock soaring to a 12- to 18-month price target of $77 a share – nearly 70% above its current price. This potential upside makes DAL one of the best stocks to buy. 

Thermo Fisher Scientific

• Sector: Healthcare
• Market value: $218.7 billion
• Dividend yield: 0.3%

Scientific research may ramp up this year, and that is promising for Thermo Fisher Scientific (TMO), which makes equipment that researchers need to do their jobs. The turnaround may take time, but patient investors could find that Thermo Fisher is one of the best stocks to buy for 2024 and beyond. 

The company's solid execution record is a plus, says R.W. Baird analyst Catherine Ramsey Schulte, who rates the stock Outperform, the equivalent of a Buy. A diverse array of customers, including biopharma firms, hospitals, diagnostic labs, universities and research institutions, among others, helps. Some of those end markets have been improving recently.  

Discover Financial Services

• Sector: Financial services
• Market value: $31.4 billion
• Dividend yield: 2.2%

Stock in Discover Financial Services (DFS) trades at a discount to its fair value, says Morningstar analyst Michael Miller. However, this spread was narrowed after Capital One (COF) in February said it plans to buy the credit card company in an all-stock deal worth $35 billion, news that sent DFS shares soaring.

About 70% of Discover's revenue is interest income from its credit cards – a plus if interest rates remain high. He adds that Discover's credit card business has historically generated better results than most of its peers. 

If economic wobbles mean consumers spend less – or worse, fail to make their card payments – that's a worry. But Discover is financially strong; Morningstar gives it an "A" for financial health, good news for investors looking for the best stocks to buy. Analysts expect flat earnings growth through 2024 compared with 2023, but they see a 26% jump in 2025, which bodes well for the financial stock.

As for the potential buyout by Capital One, Miller is neutral on the deal. While the analyst sees the strategic value for it and believes COF is paying a fair price, he notes that "there will be meaningful integration risk, and some uncertainty surrounds regulatory approval, as the combined company would be the largest credit card issuer in the United States by loan volume."

Pfizer

• Sector: Healthcare
• Market value: $154.9 billion
• Dividend yield: 6.1%

Jefferies analysts say they're being contrarian with their buy call on Pfizer (PFE). Shares of the pharmaceutical giant fell 41% in 2023, largely due to waning demand for COVID-related products. 

But the bulls at Jefferies see several catalysts for better days, including a $3.5 billion cost-cutting program that will make earnings targets more achievable. Jefferies sees earnings of $2.21 a share in 2024 and $2.75 in 2025. 

Other potential bright spots include the firm's oral obesity drug, currently in clinical trials. If viable, it has annual sales potential of $4 billion, according to Jefferies. The firm's price target for the healthcare stock is $32, implying a 17% gain.

Vulcan Materials

• Sector: Basic materials
• Market value: $36.1 billion
• Dividend yield: 0.7%

Vulcan Materials (VMC) is the largest U.S. producer of construction aggregates – think crushed stone, sand and gravel. It's also a major producer of asphalt and concrete. The company faces challenges in its residential housing construction business, but that's offset by momentum in highways and other public infrastructure. 

"We remain intrigued by the generational increase in funding" for projects driven by the Infrastructure Investment and Jobs Act of 2021, write analysts at investment firm Raymond James. 

Vulcan isn't cheap, trading at 32 times earnings estimates from a consensus of analysts. But a Street-high price target of $300 implies the materials stock could rally another 10% from recent levels, adding to its already impressive 65% year-over-year total return (price change + dividends).

Note: The original version of this article first appeared in Kiplinger's Personal Finance Magazine, a monthly, trustworthy source of advice and guidance, though it has since been updated. Subscribe to help you make more money and keep more of the money you make here.

Related content

• Best Value Stocks to Buy
• How Inflation, Deflation and Other 'Flations' Impact Your Stock Portfolio
• Why I Love Boring Stocks: Glassman